AGP Picks
View all

Africa In The News
Provided by AGP

Africa In The News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa In The News.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on July 27, 2026

UPDATE — Commerce Secretary Lutnick, Senior Counselor to President Trump Dr. Navarro, South Carolina Attorney General Wilson to Celebrate Historic 10% Increase in U.S. Aluminum Production
Jul. 27, 2026

UPDATE — Commerce Secretary Lutnick, Senior Counselor to President Trump Dr. Navarro, South Carolina Attorney General Wilson to Celebrate Historic 10% Increase in U.S. Aluminum Production

Indeterminate GlobeNewswire
Veru Announces Full Enrollment for Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
Jul. 27, 2026

Veru Announces Full Enrollment for Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss

Indeterminate GlobeNewswire
Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel
Jul. 27, 2026

Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel

Indeterminate GlobeNewswire
Spero Therapeutics Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer
Jul. 27, 2026

Spero Therapeutics Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer

Indeterminate GlobeNewswire
Micron Biomedical Secures $4.5 Million Federal Contract to Develop First Dissolvable Microarray Radiation/Nuclear Medical Countermeasure
Jul. 27, 2026

Micron Biomedical Secures $4.5 Million Federal Contract to Develop First Dissolvable Microarray Radiation/Nuclear Medical Countermeasure

Indeterminate GlobeNewswire
OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026
Jul. 27, 2026

OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026

Indeterminate GlobeNewswire
Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026
Jul. 27, 2026

Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026

Indeterminate GlobeNewswire
CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder
Jul. 27, 2026

CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder

Indeterminate GlobeNewswire
MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia
Jul. 27, 2026

MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia

Indeterminate GlobeNewswire
Belo Sun Announces Final Resolution of Civil Public Action
Jul. 27, 2026

Belo Sun Announces Final Resolution of Civil Public Action

Indeterminate GlobeNewswire
REPEAT - Helium Evolution Announces $25 Million Financing Anchored by Leading International Investors
Jul. 27, 2026

REPEAT - Helium Evolution Announces $25 Million Financing Anchored by Leading International Investors

Indeterminate GlobeNewswire
ITM Introduces Lumara Bio as Its New Oncology Therapeutics Division
Jul. 27, 2026

ITM Introduces Lumara Bio as Its New Oncology Therapeutics Division

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Africa In The News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.